Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  97 results for ""CYTOCHROME P-450 CYP2C19""

Your Filters

Publisher : future medicine ltd
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6 *6 and CYP2C19 *17 variants: a case report.

  • Authors : Stäuble CK; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland.; Pharmaceutical Care, Department of Pharmaceutical Sciences, University of Basel, 4001, Basel, Switzerland.

Subjects: Antidepressive Agents, Second-Generation/Antidepressive Agents, Second-Generation/Antidepressive Agents, Second-Generation/*therapeutic use ; Bupropion/Bupropion/Bupropion/*therapeutic use ; Cytochrome P-450 CYP2B6/Cytochrome P-450 CYP2B6/Cytochrome P-450 CYP2B6/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2020 Nov; Vol. 21 (16), pp. 1145-1150. Date of Electronic Publication: 2020 Oct 30.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

CYP2C19 genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors.

  • Authors : Petry N; Department of Pharmacy Practice, North Dakota State University, Fargo, ND 58108, USA.; Department of Internal Medicine, Sanford Health Fargo, ND 58122, USA.

Subjects: Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Long QT Syndrome/Long QT Syndrome/Long QT Syndrome/*chemically induced ; Long QT Syndrome/Long QT Syndrome/Long QT Syndrome/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 Apr; Vol. 20 (5), pp. 343-351. Date of Electronic Publication: 2019 Apr 15.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis.

  • Authors : Biswas M; Division of Pharmacogenomics & Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.

Subjects: Clopidogrel/Clopidogrel/Clopidogrel/*adverse effects ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Loss of Function Mutation/Loss of Function Mutation/Loss of Function Mutation/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2022 Feb; Vol. 23 (3), pp. 207-220. Date of Electronic Publication: 2022 Jan 19.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide.

  • Authors : Makarem YS; Department of Rheumatology & Rehabilitation, Faculty of Medicine, Assiut University, Assiut, Egypt.; Hareedy MS

Subjects: ATP Binding Cassette Transporter, Subfamily G, Member 2/ATP Binding Cassette Transporter, Subfamily G, Member 2/ATP Binding Cassette Transporter, Subfamily G, Member 2/*genetics ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Dihydroorotate Dehydrogenase/Dihydroorotate Dehydrogenase/Dihydroorotate Dehydrogenase/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2021 Dec; Vol. 22 (18), pp. 1201-1209. Date of Electronic Publication: 2021 Nov 08.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Editorial & Opinion

Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients?

Subjects: Genotype*; Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2021 Aug; Vol. 22 (12), pp. 727-730. Date of Electronic Publication: 2021 Jul 12.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The effect of CYP2C19 gene polymorphism on the eradication rate of Helicobacter pylori by proton pump inhibitors-containing regimens in Asian populations: a meta-analysis.

  • Authors : Fu J; Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.; Sun CF

Subjects: Helicobacter pylori*; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*drug therapy

  • Source: Pharmacogenomics [Pharmacogenomics] 2021 Aug; Vol. 22 (13), pp. 859-879. Date of Electronic Publication: 2021 Aug 20.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.

  • Authors : Brown JT; Department of Pharmacy Practice & Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN 55812, USA.; Schneiderhan M

Subjects: Clomipramine/Clomipramine/Clomipramine/*analogs & derivatives ; Clomipramine/Clomipramine/Clomipramine/*blood ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*metabolism

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 May; Vol. 18 (7), pp. 601-605. Date of Electronic Publication: 2017 May 04.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?

  • Authors : Taranu A; INSERM UMR1178, Team (Depression & Antidepressants), Faculté de Médecine Paris-Sud, Univ. Paris-Sud, Le Kremlin Bicêtre, France.; Colle R

Subjects: Genotype*; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 May; Vol. 18 (7), pp. 639-650. Date of Electronic Publication: 2017 May 08.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.

  • Authors : Bahar MA; Department of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.

Subjects: Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Cytochrome P-450 CYP2C9/Cytochrome P-450 CYP2C9/Cytochrome P-450 CYP2C9/*genetics ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 May; Vol. 18 (7), pp. 701-739. Date of Electronic Publication: 2017 May 08.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters.

  • Authors : Kanjanasilp J; Clinical Trials & Evidence-Based Synthesis Research Unit, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, 44150, Thailand.; Sawangjit R

Subjects: Anticonvulsants/Anticonvulsants/Anticonvulsants/*pharmacokinetics ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Cytochrome P-450 CYP2C9/Cytochrome P-450 CYP2C9/Cytochrome P-450 CYP2C9/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2021 Jul; Vol. 22 (10), pp. 629-640. Date of Electronic Publication: 2021 Jun 01.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  97 results for ""CYTOCHROME P-450 CYP2C19""